Addressing the growing problem of antibiotic resistance requires the development of new drugs with novel antibacterial targets. FtsZ has been identified as an appealing new target for antibacterial agents. Here, we describe the structure-guided design of a new fluorescent probe (BOFP) in which a BODIPY fluorophore has been conjugated to an oxazole-benzamide FtsZ inhibitor. Crystallographic studies have enabled us to identify the optimal position for tethering the fluorophore that facilitates the high-affinity FtsZ binding of BOFP. Fluorescence anisotropy studies demonstrate that BOFP binds the FtsZ proteins from the Gram-positive pathogens Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, Streptococcus pyogenes, Streptococcus agalactiae, and Streptococcus pneumoniae with Kd values of 0.6-4.6 µM. Significantly, BOFP binds the FtsZ proteins from the Gram-negative pathogens Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii with an even higher affinity (Kd = 0.2-0.8 µM). Fluorescence microscopy studies reveal that BOFP can effectively label FtsZ in all the above Gram-positive and Gram-negative pathogens. In addition, BOFP is effective at monitoring the impact of non-fluorescent inhibitors on FtsZ localization in these target pathogens. Viewed as a whole, our results highlight the utility of BOFP as a powerful tool for identifying new broad-spectrum FtsZ inhibitors and understanding their mechanisms of action.
Conflict of interest statement
The authors declare no competing interests.
Fluorescence High-Throughput Screening for Inhibitors of TonB Action.J Bacteriol. 2017 Apr 25;199(10):e00889-16. doi: 10.1128/JB.00889-16. Print 2017 May 15. J Bacteriol. 2017. PMID: 28242720 Free PMC article.
[Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].Zhonghua Shao Shang Za Zhi. 2018 Nov 20;34(11):802-808. doi: 10.3760/cma.j.issn.1009-2587.2018.11.016. Zhonghua Shao Shang Za Zhi. 2018. PMID: 30481922 Chinese.
Inhibition of RND-type efflux pumps confers the FtsZ-directed prodrug TXY436 with activity against Gram-negative bacteria.Biochem Pharmacol. 2014 Jun 1;89(3):321-8. doi: 10.1016/j.bcp.2014.03.002. Epub 2014 Mar 14. Biochem Pharmacol. 2014. PMID: 24637241
Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.FEMS Microbiol Rev. 2011 Sep;35(5):872-900. doi: 10.1111/j.1574-6976.2011.00284.x. Epub 2011 Jul 4. FEMS Microbiol Rev. 2011. PMID: 21658083 Free PMC article. Review.
[Antibacterial drug resistance in Latin America: consequences for infectious disease control].Rev Panam Salud Publica. 2011 Dec;30(6):519-28. Rev Panam Salud Publica. 2011. PMID: 22358396 Review. Spanish.
- World Health Organization. Antimicrobial resistance: global report on surveillance. (World Health Organization, 2014).
- World Health Organization. Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline, Including Tuberculosis. 48 (Geneva, Switzerland, 2017).
- R25 GM058389/GM/NIGMS NIH HHS/United States
- R01 AI118874/AI/NIAID NIH HHS/United States
- 17H05732, 18K06094, 19H04735, 19K07582/MEXT | Japan Society for the Promotion of Science (JSPS)
- AI118874/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- 19K16060/MEXT | Japan Society for the Promotion of Science (JSPS)